文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

姜黄素对模拟干热环境下中暑大鼠外周血CD11b和CD19表达的影响

[Effect of curcumin on expressions of CD11b and CD19 in peripheral blood of heat stroke rats in a simulation dry-heat environment].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论大鼠实验显示姜黄素预处理可降低干热中暑早期和中期外周血CD11b水平、升高CD19水平,作者认为可能通过增强免疫力提高耐热性并预防多器官功能障碍。

该研究将160只SPF健康雄性Sprague-Dawley大鼠按随机数字表法分为生理盐水对照组、溶剂对照组(羧甲基纤维素钠CMCNa)及姜黄素低、中、高剂量预处理组(0.05、0.10、0.20 mg/g姜黄素+0.5% CMCNa溶液),每组32只,连续灌胃给药7天。第8天在人工实验室模拟西北干热环境(环境温度41.0±0.5℃、相对湿度10±1%)中分别放置0、50、100、150分钟,用流式细胞仪检测外周血CD19和CD11b水平。随放置时间延长各组CD11b逐渐升高并于150分钟达峰值,CD19先升高后降低并于100分钟达峰值。姜黄素中、高剂量预处理组CD11b在50分钟和100分钟显著低于生理盐水对照组和溶剂对照组,高剂量组150分钟CD11b显著低于其余三组;低剂量组CD19在50分钟和100分钟显著高于两对照组。作者结论认为姜黄素预处理可降低干热中暑大鼠早中期CD11b水平、升高CD19水平,可能通过增强机体免疫力提高耐热性并预防多器官功能障碍,且该作用与姜黄素剂量无关。

要点

  • 大鼠干热环境(41.0±0.5℃、相对湿度10±1%)暴露后CD11b随时间逐渐升高,150分钟达峰值,生理盐水对照组为0.346±0.013。
  • 姜黄素高剂量预处理组150分钟CD11b为0.281±0.012,显著低于生理盐水对照组0.346±0.013、溶剂对照组0.342±0.013和低剂量组0.342±0.012(均P<0.05)。
  • 姜黄素中、高剂量组50分钟CD11b分别为0.237±0.011、0.188±0.006,显著低于生理盐水对照组0.283±0.009和溶剂对照组0.289±0.012(均P<0.05)。
  • CD19在干热环境100分钟达峰值,低剂量姜黄素组为0.684±0.009,显著高于生理盐水对照组0.586±0.010和溶剂对照组0.601±0.014(均P<0.05)。
  • 作者认为姜黄素预处理降低CD11b、升高CD19的作用与剂量无关,可能通过增强免疫力提高耐热性并预防多器官功能障碍。

适用人群与场景

  • SPF健康雄性Sprague-Dawley(SD)大鼠,共160只,每组32只,用于模拟干热环境中暑模型。
  • 动物在人工实验室模拟中国西北干热环境(环境温度41.0±0.5℃、相对湿度10±1%)中暴露0、50、100、150分钟。

处置流程与药物剂量

  • 姜黄素低、中、高剂量预处理组分别给予0.05、0.10、0.20 mg/g姜黄素+0.5% CMCNa溶液灌胃,给药体积10 mL×kg-1×d-1,连续给药7天。
  • 生理盐水对照组给予生理盐水,溶剂对照组给予羧甲基纤维素钠(CMCNa),均按10 mL×kg-1×d-1灌胃,连续7天。

研究设计与关键结果

  • 研究类型为动物实验,160只SPF健康雄性SD大鼠随机分为生理盐水对照组、溶剂对照组及姜黄素低、中、高剂量预处理组,每组32只。
  • 随干热环境暴露时间延长,各组外周血CD11b逐渐升高并于150分钟达峰值:生理盐水对照组0.346±0.013、溶剂对照组0.342±0.013、姜黄素低剂量组0.342±0.012、中剂量组0.325±0.012、高剂量组0.281±0.012。
  • 各组CD19先升高后降低并于100分钟达峰值:生理盐水对照组0.586±0.010、溶剂对照组0.601±0.014、姜黄素低剂量组0.684±0.009、中剂量组0.613±0.012、高剂量组0.604±0.006。
  • 姜黄素中、高剂量组CD11b在50分钟分别为0.237±0.011、0.188±0.006,显著低于生理盐水对照组0.283±0.009和溶剂对照组0.289±0.012(均P<0.05);100分钟分别为0.260±0.010、0.248±0.008,显著低于生理盐水对照组0.293±0.008和溶剂对照组0.290±0.007(均P<0.05)。
  • 150分钟时姜黄素高剂量组CD11b为0.281±0.012,显著低于生理盐水对照组0.346±0.013、溶剂对照组0.342±0.013和姜黄素低剂量组0.342±0.012(均P<0.05)。
  • 干热环境50分钟时姜黄素低、中、高剂量组CD19分别为0.394±0.001、0.436±0.009、0.553±0.011,显著高于生理盐水对照组0.205±0.005和溶剂对照组0.197±0.003(均P<0.05);100分钟时姜黄素低剂量组CD19为0.684±0.009,显著高于生理盐水对照组0.586±0.010和溶剂对照组0.601±0.014(均P<0.05),其余剂量预处理组与生理盐水对照组CD19水平差异无显著意义;150分钟时姜黄素预处理组、生理盐水对照组和溶剂对照组CD19水平差异无显著意义。
  • 生理盐水对照组和溶剂对照组外周血免疫因子CD11b和CD19水平无显著变化,两组间差异无显著意义。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠干热中暑模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为姜黄素预处理可降低干热中暑大鼠早期和中期外周血CD11b水平、升高CD19水平,可能通过增强机体免疫力提高耐热性并预防多器官功能障碍,且该作用与姜黄素剂量无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the effects of different doses of curcumin on the levels of immune factors CD11b and CD19 in peripheral blood of heat stroke rats in a simulation dry-heat environment.

METHODS: 160 SPF healthy male Sprague-Dawley (SD) rats were selected and divided into different groups according to random number table method: normal saline (NS) control group (given NS), solvent control group [given sodium carboxymethylcellulose (CMCNa)], and curcumin low, medium and high dose pretreatment group (given 0.05, 0.10, 0.20 mg/g of curcumin+0.5% CMCNa solution). There were 32 rats in each group, and were challenged only by 10 mL×kg-1×d-1 lavage, and continuous dosing for 7 days. On the 8th day, rats were challenged at ambient temperature (41.0±0.5) centigrade, relative humidity (10±1)% of the northwest in the special environment of artificial lab, placed in 0 (normal temperature), 50, 100 and 150 minutes respectively. The levels of CD19 and CD11b in peripheral blood of each rat were detected by flow cytometry instrument.

RESULTS: With the extension of time in the simulated dry and heat environment, the level of CD11b in peripheral blood was gradually increased in each group, and the peak value was reached at 150 minutes, the NS control group, solvent control group and curcumin low, medium and high dose pretreatment groups were 0.346±0.013, 0.342±0.013, 0.342±0.012, 0.325±0.012, and 0.281±0.012, respectively. In each group, the level of CD19 was first increased and then decreased, reaching its peak value at 100 minutes, and the level of the NS control group, solvent control group and curcumin low, medium and high dose pretreatment groups were 0.586±0.010, 0.601±0.014, 0.684±0.009, 0.613±0.012 and 0.604±0.006, respectively. The level of CD11b in the curcumin medium and high dose pretreatment groups were significantly lower than those in the NS control group and solvent control group (50 minutes: 0.237±0.011, 0.188±0.006 vs. 0.283±0.009, 0.289±0.012; 100 minutes: 0.260±0.010, 0.248±0.008 vs. 0.293±0.008, 0.290±0.007, all P < 0.05), and after placement for 150 minutes, the level of CD11b in the curcumin high dose pretreatment group was significantly lower than that in the NS control group, solvent control group and curcumin low dose pretreatment group (0.281±0.012 vs. 0.346±0.013, 0.342±0.013, 0.342±0.012, all P < 0.05). The level of CD19 in the curcumin low, medium and high dose pretreatment groups were significantly higher than those in the NS control group and solvent control group at 50 minutes in the dry and hot environment (0.394±0.001, 0.436±0.009, 0.553±0.011 vs. 0.205±0.005, 0.197±0.003, all P < 0.05), at 100 minutes, the level of CD19 in the curcumin low dose pretreatment group was significantly higher than that in the NS control group and solvent control group (0.684±0.009 vs. 0.586±0.010, 0.601±0.014, both P < 0.05), there was no significant difference in CD19 level between the other dose pretreatment groups and NS control group; at 150 minutes, there was no significant difference in CD19 level between the curcumin pretreatment groups, the NS control group, and the solvent control group. The peripheral blood immune factors CD11b and CD19 levels in the NS control group and solvent control group were not significantly changed, and there was no significant difference between two groups.

CONCLUSIONS: Curcumin pretreatment can reduce the level of CD11b and increase the level of CD19 in peripheral blood of rats with dry heat stroke in the early and middle stages, which may enhance the heat resistance and prevent the occurrence of multiple organ dysfunction by increasing the body immunity, and this effect has nothing to do with the dose of curcumin.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Jiang J, Liu J, Li J, et al. [Effect of curcumin on expressions of CD11b and CD19 in peripheral blood of heat stroke rats in a simulation dry-heat environment]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 30827313. doi:10.3760/cma.j.issn.2095-4352.2019.02.019

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。